1-1312487-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_017871.6(INTS11):c.1417G>A(p.Ala473Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000038 in 1,580,158 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_017871.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
INTS11 | NM_017871.6 | c.1417G>A | p.Ala473Thr | missense_variant | 14/17 | ENST00000435064.6 | NP_060341.2 | |
MIR6727 | NR_106785.1 | downstream_gene_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
INTS11 | ENST00000435064.6 | c.1417G>A | p.Ala473Thr | missense_variant | 14/17 | 1 | NM_017871.6 | ENSP00000413493 | P1 | |
MIR6727 | ENST00000620702.1 | downstream_gene_variant |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152158Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000156 AC: 3AN: 192842Hom.: 0 AF XY: 0.0000287 AC XY: 3AN XY: 104528
GnomAD4 exome AF: 0.0000406 AC: 58AN: 1428000Hom.: 0 Cov.: 36 AF XY: 0.0000382 AC XY: 27AN XY: 707702
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152158Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74334
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 04, 2022 | The c.1417G>A (p.A473T) alteration is located in exon 14 (coding exon 14) of the CPSF3L gene. This alteration results from a G to A substitution at nucleotide position 1417, causing the alanine (A) at amino acid position 473 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at